return to news
  1. Stocks to watch, Feb 1: Hero MotorCorp, Sun Pharma, ONGC, ITC, Marico, Vedanta and more

Market News

Stocks to watch, Feb 1: Hero MotorCorp, Sun Pharma, ONGC, ITC, Marico, Vedanta and more

Upstox

7 min read | Updated on February 01, 2025, 08:30 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Shares of Hero MotorCorp to remain in focus as the company on Friday said CEO Niranjan Gupta is stepping down with effect from April 30

FMCG, defence, PSU, electronics, agriculture, railway stocks to remain in focus during the Budget day. Image: Shutterstock

FMCG, defence, PSU, electronics, agriculture, railway stocks to remain in focus during the Budget day. Image: Shutterstock

Stocks to watch: Indian benchmark indices are expected to remain volatile on Saturday, February 1 as investors may remain cautious ahead of the Union budget.

Indian markets are expected to open positively on Saturday before the Union Budget session. The markets posted a strong recovery during the week, rising nearly 3.2% from the recent lows. The broader market indices recovered more fiercely, rising 5% from the lower levels.

On the global front, the US markets fell from near-record high levels on Friday after the Trump administration confirmed imposing tariffs on China, Mexico, and Canada.

Earnings today: Aarti Industries, Anant Raj, Apex Frozen Foods, G R Infraprojects, Jaiprakash Power Ventures, Neogen Chemicals, Vinati Organics, and Windsor Machines will announce their quarterly earnings on Saturday.
Here is a list of stocks that will remain in focus on the Budget day.
Railways

Stocks in focus: Rail Vikas Nigam, IRCTC, IRFC, Railtel, IRCON, Jupiter Wagon, Titagarh Wagon.

Indian railways sector has seen sharp upheaval in the past decade after the government decided to improve the quality of India’s largest passenger travel mode. Experts anticipate Finance Minister Nirmala Sitharaman increasing capital expenditure for the railway sector by 15-20% in the upcoming Union Budget 2025.

Public sector undertakings

Stocks in focus: SBI, LIC, Hindustan Zinc, Cochin Shipyard, IDBI Bank, Shipping Corporation of India, Mazagon Dock Shipbuilders, BHEL, IREDA, BPCL, HPCL, Punjab National Bank, Canara Bank, NHPC and more.

The government could not achieve its ambitious divestment target for public sector undertakings in FY25. However, experts suggest that the FY26 budget estimates for divestment are expected to be more realistic.

Agriculture

Stocks in focus: Fertiliser stocks like Coromandel International, RCF, and Madras Fertilizer. Fisheries stocks related to shrimp feeds like Avanti Feeds and Apex Frozen Food. Small Finance companies like Credit Access Grameen, Unity Small Finance, AU Small Finance and more.

The agriculture sector has always received more focus from the government in the budget as the majority of the population is reliant on agriculture and allied activities. According to media reports, the sector is expected to receive increased allocation to ₹1.75 lakh crore and a limit on loans from Kisan credit cards.

Defence sector

Stocks in focus: Hindustan Aeronautics Ltd, Bharat Electronics Ltd, Garden Reach Shipbuilders & Engineers, Bharat Dynamics Ltd, Cochin Shipyard, Data Patterns, Apollo Micro Systems, Astra Microwave Products, MTAR Technologies.

The defence sector has been in focus for many budgets with increased allocation for spending and upgradation of existing sources. Each year, the defence sector has seen some announcements in the budget.

Electronics manufacturing

Stocks in focus: Dixon Technologies, Amber Enterprises, PG Electroplast, Kaynes Technologies, Epack Durable.

The government of India is expected to continue supporting electronic manufacturing services (EMS) players through a production-linked investment scheme. According to media reports, the government is expected to announce a PLI scheme worth ₹25,000 crore for electronic component manufacturers and ₹43,000 crore for semiconductors.

FMCG

Stocks in focus: ITC, Hindustan Unilever, Maruti Suzuki, Godrej Consumer Products, Marico, Adani Wilmar.

The urban FMCG sector, a major contributor to India’s consumption story, is experiencing a slowdown, particularly in mass-market segments. Rural markets, comprising 35% of India’s FMCG sales, are rebounding with a 6% year-on-year growth in volume sales. Getting demand levels back on track is a top priority for industry leaders to spark growth in the consumption sector. For analysts, this remains important, as subdued macros and a complicated geopolitical picture are already weighing down FMCG stocks.

Stocks to watch
Vedanta: Vedanta on Friday, January 31 announced a 70.18% year-on-year (YoY) jump in its consolidated profit after tax (PAT) to ₹4,876 crore in Q3 FY25 from ₹2,868 crore in the year-ago period.

Its revenue from operations rose 10.18% to stand at ₹38,526 crore, compared to ₹34,968 crore in Q3 FY24.

ONGC: State-owned Oil and Natural Gas Corporation (ONGC) on Friday reported a 16.7% drop in its third-quarter net profit as it realised lower rates for crude oil it produces. Standalone net profit was at ₹8,240 crore in October-December 2024 compared with ₹9,892 crore in the same period a year back, according to a company statement.
Sun Pharma: The pharma on Friday said its consolidated net profit increased 15% on-year to ₹2,903 crore in the December quarter, riding on robust sales across geographies. Sun Pharmaceutical Industries had reported a net profit of ₹2,524 crore in the October-December quarter of last fiscal.

Total revenue from operations rose to ₹13,675 crore in the third quarter compared to ₹12,381 crore in the year-ago period, the company said in a regulatory filing.

The drug maker's board has declared an interim dividend of ₹10.5 per share for the year FY25 against ₹8.50 per share interim dividend for the previous year.

IndusInd Bank: IndusInd Bank on Friday, January 31 announced a 39% YoY decrease in its standalone net profit to ₹1,402.3 crore in Q3 FY25 from ₹2,301 crore in the year-ago period.

Its Net Interest Income (NII) fell 1.28% YoY to stands at ₹5,228.1 crore, compared to ₹5,295.6 crores in Q3 FY24.

The bank's gross NPA's increased 9.66% to ₹8,375.3 crore from ₹7,638.5 crore in the previous quarter.

Bandhan Bank: Bandhan Bank on Friday, January 31 declared a 41.79% YoY decrease in its standalone net profit to ₹426.49 crore in Q3 FY25 from ₹732.72 crore in the year-ago period.

Its net interest income (NII) rose 12% YoY to stands at ₹2,830 crore, compared to ₹2,525 crores in Q3 FY24. The bank's gross NPA's fell 24.06% to ₹6,178.5 crore from ₹8,135.54 crore in the previous quarter.

Pfizer: Pfizer Ltd on Friday, January 31 announced a 1.95% year-on-year (YoY) fall in its net profit to ₹127.44 crore in Q3 FY25 from ₹129.98 crore in the year-ago period.

Its revenue from operations decreased 0.37% to stand at ₹537.99 crore, compared to ₹539.97 crore in Q3 FY24.

Godrej Agrovet: The agribusiness company reported a strong performance for Q3 FY25, with its net profit increasing by 32.4% year-on-year to ₹109.9 crore, up from ₹83 crore in the same quarter last year. The company’s revenue rose 4.5% to ₹2,449.6 crore, compared to ₹2,345.2 crore in Q3 FY24.

Godrej Agrovet saw a significant 38.4% growth in EBITDA, which stood at ₹220 crore, up from ₹159 crore in the corresponding period last year.

Marico: The FMCH company on Friday, January 31 declared a 4.2% year-on-year (YoY) increase in its consolidated net profit to ₹399 crore for the three months ended December 31, 2024 (Q3 FY25), compared to ₹383 crore in the corresponding period a year ago.

The FMCG company’s revenue from operations rose 15.4% YoY to ₹2,794 crore as against ₹2,422 crore in the third quarter ended December 31, 2023 (Q3 FY24).

Hero MotoCorp: The company on Friday announced that its Chief Executive Officer (CEO) Niranjan Gupta is stepping down with effect from April 30 as he has decided to "pursue other opportunities". Gupta's tenure was exactly two years. The company's Executive Director (Operations) Vikram Kasbekar has been appointed as the acting CEO with effect from May 1.
Aurobindo Pharma: The company's subsidiary, CuraTeQ Biologics s.r.o., has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) within the European Medicines Agency (EMA) for Dyrupeg, recommending the granting of a marketing authorization.
Upstox

About The Author

Upstox
Upstox News Desk is a team of journalists who passionately cover stock markets, economy, commodities, latest business trends, and personal finance.

Next Story